About Us


Zdravlje is a fully integrated developer, manufacturer and distributor of biopharmaceuticals with a proven track record spanning 70 years.  As of April 2021 we are under the ownership and management of Frontier Baystone, a UK-based specialist pharmaceutical investor and operator comprising biopharmaceutical industry veterans with a track record of building successful multinational companies. We employ more than 320 people and supply approximately 40 countries across the world (spanning Europe, UK, Latin America, Asia-Pacific and Africa) with high quality pharmaceuticals from our EU-GMP approved manufacturing facility.


Our strategy is to address unmet medical needs through the delivery of innovative and differentiated products across growth markets in Central and Eastern Europe. We focus chronic and niche therapies across prescription and consumer health areas.


We are a trusted partner of choice for companies seeking high quality, dependable development and manufacturing services and those who are looking to access high value markets across Central and Eastern Europe, ex-Yugoslavia and CIS.


We are pioneering various biotechnology and biologic projects to make these innovative treatments more accessible to patients across emerging markets and Europe. Our core focus includes monoclonal antibodies, vaccines, insulin, blood derivates and immunotherapies.



+381 60 790 2200

Vlajkova St. 199, 16000 Leskovac, SerbiaMilutina Milankovica Blvd. 23, Belgrade, Serbia